Literature DB >> 16884884

Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-beta-hydroxybutyrate microspheres.

Tao Hu1, Qihua Le, Zhiyi Wu, Wei Wu.   

Abstract

A validated HPLC method was developed for the quantification of doxorubicin in rabbit ocular tissues using solid phase extraction and ultraviolet detection. Chromatographic separation of doxorubicin in various ocular tissues was performed on a C18 column. The mobile phase was composed of 0.2 M KH2PO4 buffer solution, acetonitrile and triethylamine in volumetric ratio of 70/30/0.2, adjusted to pH 4.0 with orthophosphoric acid. The calibration curve was linear over the range of 0.03-10, 0.03-10, 0.05-10 and 0.05-10 microg/ml in vitreous body, iris, retina/choroids and sclera, respectively. The intra-day and inter-day precisions in all ocular tissues were smaller than 4.95% and 5.73%, and the accuracies were about 100%. The extraction recoveries of doxorubicin in all of the ocular tissues were between 83.47% and 96.33%. After intravitreal administration of doxorubicin-loaded poly-beta-hydroxybutyrate microspheres, doxorubicin level in ocular tissues was much lower than that for administration of free doxorubicin, which was helpful to reduce the associated toxicity to surrounding tissues. Doxorubicin was detectable even after tens of days in the studied ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884884     DOI: 10.1016/j.jpba.2006.06.032

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

Review 1.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

2.  Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation.

Authors:  Esther S Kim; Chandrasekar Durairaj; Rajendra S Kadam; Sung Jin Lee; Yun Mo; Dayle H Geroski; Uday B Kompella; Henry F Edelhauser
Journal:  Pharm Res       Date:  2009-02-05       Impact factor: 4.200

Review 3.  Review: New horizons in retinoblastoma treatment: an updated review article.

Authors:  Fatemeh Azimi; Reza Mirshahi; Masood Naseripour
Journal:  Mol Vis       Date:  2022-07-11       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.